BeyondSpring Inc.
Business
BeyondSpring Inc. is a clinical-stage biopharmaceutical company developing innovative cancer therapies. Its lead asset, Plinabulin, is a brain-penetrant microtubule modulator in late-stage development across multiple cancer indications. The company also holds an equity stake in SEED Therapeutics, which develops targeted protein degradation therapeutics using a proprietary molecular glue platform. BeyondSpring operates globally with offices in New Jersey, Beijing, and Dalian.
Summary from 10-K filed 2026-03-25
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | |
| Research and development | −4 | −3 | −7 | |
| General and administrative | −5 | −6 | −8 | |
| Loss from operations | −9 | −9 | −15 | |
| Foreign exchange gain (loss), net | 165,000 | −96,000 | −128,000 | |
| Interest income | 78,000 | 59,000 | 322,000 | |
| Other income, net | 77,000 | 22,000 | 964,000 | |
| Loss before income tax | −9 | −9 | −14 | |
| Income tax expenses | −90,000 | −96,000 | −92,000 | |
| Net loss from continuing operations | −9 | −9 | −14 | |
| Loss from discontinued operations | −12 | −8 | −8 | |
| Gain on disposal of discontinued operations | 7 | 0 | — | |
| Income tax expenses | 0 | 0 | −14,000 | |
| Net loss from discontinued operations | −6 | −8 | −8 | |
| Net loss | −14 | −17 | −22 | |
| Less: Net loss attributable to noncontrolling interests from continuing operations | −242,000 | −388,000 | −922,000 | |
| Less: Net loss attributable to noncontrolling interests from discontinued operations | −13 | −5 | 0 | |
| Net loss attributable to BeyondSpring Inc. | −1 | −11 | −21 | |
| Continuing operations (in dollars per share) | −0.21 | −0.21 | −0.34 | |
| Discontinued operations (in dollars per share) | — | −0.07 | −0.2 | |
| Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share (in dollars per share) | 0.19 | — | — | |
| Basic and diluted earnings (loss) per share (in dollars per share) | −0.02 | −0.28 | −0.54 | |
| Basic and diluted (in shares) | 40 | 40 | 39 | |
| Comprehensive loss | −15 | −16 | −21 | |
| Comprehensive loss attributable to BeyondSpring Inc. | −2 | −11 | −21 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 8 | 3 | 5 | — | |
| Short-term investments | 5 | 0 | — | — | |
| Advances to suppliers | 227,000 | 240,000 | 292,000 | — | |
| Prepaid expenses and other current assets | 71,000 | 68,000 | 168,000 | — | |
| Current assets of discontinued operations | 8 | 25 | 3 | — | |
| Total current assets | 21 | 29 | 18 | — | |
| Property and equipment, net | 166,000 | 239,000 | 317,000 | — | |
| Operating right-of-use assets | 305,000 | 513,000 | 730,000 | — | |
| Other noncurrent assets | 224,000 | 213,000 | 123,000 | — | |
| Noncurrent assets of discontinued operations | 4 | 5 | 5 | — | |
| Total noncurrent assets | 5 | 6 | 6 | — | |
| Total assets | 26 | 34 | 25 | — | |
| Accounts payable | 363,000 | 295,000 | 561,000 | — | |
| Accrued expenses | 938,000 | 840,000 | 2 | — | |
| Current portion of operating lease liabilities | 320,000 | 282,000 | 258,000 | — | |
| Other current liabilities | 822,000 | 780,000 | 1 | — | |
| Current liabilities of discontinued operations | 11 | 9 | 4 | — | |
| Total current liabilities | 14 | 11 | 8 | — | |
| Operating lease liabilities | 0 | 307,000 | 589,000 | — | |
| Deferred revenue | 29 | 27 | 28 | — | |
| Other noncurrent liabilities | 4 | 4 | 4 | — | |
| Noncurrent liabilities of discontinued operations | 4 | 6 | 8 | — | |
| Total noncurrent liabilities | 36 | 38 | 40 | — | |
| Total liabilities | 50 | 49 | 48 | — | |
| Commitments and Contingencies | — | — | — | — | |
| Ordinary shares ($0.0001 par value; 500,000,000 shares authorized; 40,316,320 and 41,122,320 shares issued and outstanding as of December 31, 2024 and 2025, respectively) | 4,000 | 4,000 | 4,000 | — | |
| Additional paid-in capital | 376 | 373 | 369 | — | |
| Accumulated deficit | −408 | −407 | −396 | — | |
| Accumulated other comprehensive income | 602,000 | 1 | 894,000 | — | |
| Total BeyondSpring Inc.s shareholders deficit | −32 | −33 | −27 | — | |
| Noncontrolling interests | 8 | 19 | −9 | — | |
| Total shareholders deficit | −24 | −14 | −35 | −14 | |
| Total liabilities and shareholders deficit | 26 | 34 | 25 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Depreciation expenses | 87,000 | 285,000 | 302,000 | |
| Share-based compensation | 722,000 | 2 | 770,000 | |
| Non-cash operating lease expenses | 747,000 | 702,000 | 1 | |
| Unrealized gain on short-term investments | 0 | −3,000 | 4,000 | |
| Gain on sale of subsidiary interests | −7 | 0 | — | |
| Short-term investments | 254,000 | −64,000 | 3 | |
| Advances to suppliers | −18,000 | −19,000 | 186,000 | |
| Prepaid expenses and other current assets | 64,000 | 10,000 | −593,000 | |
| Other noncurrent assets | −42,000 | −117,000 | 17,000 | |
| Accounts payable | −76,000 | −607,000 | 326,000 | |
| Accrued expenses | 2 | −387,000 | 111,000 | |
| Operating lease liabilities | −709,000 | −631,000 | −966,000 | |
| Other current liabilities | 268,000 | −163,000 | 113,000 | |
| Deferred revenue | −2 | −1 | 249,000 | |
| Other noncurrent liabilities | 296,000 | −10,000 | 30,000 | |
| Net cash used in operating activities | −20 | −16 | −16 | |
| Acquisitions of property and equipment | −50,000 | −224,000 | 100,000 | |
| Purchase of short-term investments | −15 | −13 | 1 | |
| Proceeds from maturity of short-term investments | 18 | 1 | 1 | |
| Proceeds from sale of subsidiary interests | 7 | 0 | — | |
| Net cash (used in) provided by investing activities | 11 | −12 | −100,000 | |
| Proceeds from issuance of ordinary shares | 2 | 3 | 0 | |
| Capital contribution from noncontrolling interests | 3 | 20 | 0 | |
| Proceeds from loans | 286,000 | 4 | 0 | |
| Net cash provided by financing activities | 5 | 27 | 4,000 | |
| Effect of foreign exchange rate changes | 105,000 | −33,000 | −76,000 | |
| Net decrease in cash and cash equivalents | −4 | −2 | −17 | |
| Interest paid | 0 | 0 | 0 | |
| Interest received | 311,000 | 148,000 | 462,000 | |
| Income taxes paid | 2,000 | 7,000 | 36,000 | |
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | 40,000 | 0 | — | |
| Issuance costs accrued in accrued expenses | 8,000 | 0 | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is BeyondSpring Inc.'s CIK number?
BeyondSpring Inc.'s SEC CIK number is 0001677940 (1677940). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find BeyondSpring Inc.'s SEC filings?
All of BeyondSpring Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did BeyondSpring Inc. last report earnings?
BeyondSpring Inc. (BYSI) most recently filed an earnings 8-K with the SEC on May 13, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001171843-26-003344). This is BeyondSpring Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is BeyondSpring Inc.'s most recent earnings 8-K?
BeyondSpring Inc.'s latest earnings 8-K (Item 2.02) was filed May 13, 2026 under accession 0001171843-26-003344. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View BeyondSpring Inc.'s latest earnings 8-K →
Look up any company's CIK number →